Title:
USE OF PYRIDINYL SULFONAMIDE PHOSPHATE COMPOUND IN PREPARING ANTI-CEREBRAL EDEMA DRUG
Document Type and Number:
WIPO Patent Application WO/2023/185911
Kind Code:
A1
Abstract:
Use of a pyridinyl sulfonamide phosphate compound or a pharmaceutical composition comprising same in preparing an anti-cerebral edema drug. The pyridinyl sulfonamide phosphate compound can quickly reduce intracranial pressure and is used for treating cerebral edema caused by various reasons and preventing cerebral hernia. The compound is very safe and does not have serious adverse effects such as liver and kidney injury. The compound is expected to become a new clinical anti-cerebral edema drug. The compound has very wide clinical application.
Inventors:
WEI NONGNONG (CN)
WENG ZHIJIE (CN)
JIN HUA (CN)
SU MIN (CN)
WENG ZHIJIE (CN)
JIN HUA (CN)
SU MIN (CN)
Application Number:
PCT/CN2023/084636
Publication Date:
October 05, 2023
Filing Date:
March 29, 2023
Export Citation:
Assignee:
SHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
A61K31/675; A61P7/10; A61P25/00; C07F9/58
Foreign References:
| CN114796241A | 2022-07-29 | |||
| CN110606860A | 2019-12-24 | |||
| EP0151451A1 | 1985-08-14 |
Other References:
"Cerebral Stroke Health Management", 28 February 2015, MILITARY MEDICAL SCIENCE PRESS, CN, ISBN: 978-7-5163-0530-0, article ZHOU, HONGZHEN ET AL.: "Chapter II Treatment and Nursing of Cerebral Stroke", pages: 101 - 103, XP009550272
TANG, TIEYU ET AL.: "Section II Cerebral Edema Treatment", NERVOUS CRITICAL CARE AND DIAGNOSIS AND TREATMENT, 31 July 2019 (2019-07-31)
TANG, TIEYU ET AL.: "Section II Cerebral Edema Treatment", NERVOUS CRITICAL CARE AND DIAGNOSIS AND TREATMENT, 31 July 2019 (2019-07-31)
Attorney, Agent or Firm:
BEIJING TANLULAI PATENT AGENT LTD et al. (CN)
Download PDF: